Polyp Detection Rate After Single Oral Dose of Methylene Blue MMX Modified Release Tablets Administered to Subjects Undergoing Outpatients Colonoscopy

N/ACompletedNCT01520337

Cosmo Technologies Ltd170 enrolled

Overview

Polyp detection rate in colonoscopy following oral administration of MMX methylene blue tablets

Polyp detection rate in colonoscopy following oral administration of methylene blue MMX modified release tablets in subjects undergoing colonoscopy as outpatients.

Study Type

OBSERVATIONAL

Enrollment

170

Conditions

Polyp and Adenoma Detection During Colonoscopy

Interventions

oral tablet dye for detection of polyps during colonoscopyDEVICE

oral tablet dye for improved detection of

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients scheduled for screening or surveillance colonoscopy. Written informed consent.Practising reliable contraception or sterile.Ability to understand and comply with the protocol. Exclusion Criteria: * Pregnancy or lactation known or suspected hypersensitivity GI obstruction or perforation serious cardiovascular, renal or hepatic disease. reduced prothrombin time,elevated serum creatinine.

Outcomes

Primary Outcomes

Polyp and adenoma detection rate

Time frame: 1 day

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.